HMGB1/RAGE/TLR4 axis and glutamate as novel targets for PCSK9 inhibitor in high fat cholesterol diet induced cognitive impairment and amyloidosis
Sally A. Abuelezz, Nevien Hendawy
Topics & Concepts
PCSK9CholesterolEndocrinologyInternal medicineTREM2NeurodegenerationKexinLiver X receptorLDL receptorGlycationMedicineChemistryInflammationReceptorLipoproteinBiochemistryMicrogliaNuclear receptorGeneDiseaseTranscription factorAdvanced Glycation End Products researchAlzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration Mechanisms